MP-1032 is under clinical development by MetrioPharm and currently in Phase I for Multiple Sclerosis. According to GlobalData, Phase I drugs for Multiple Sclerosis have a 72% phase transition success ...
With psoriasis, it’s important to avoid foods that can trigger inflammation. Inflammation and the immune system response can lead to a flare-up. Reducing triggers is an important part of ...
There’s no cure for psoriasis, but treatment can help you feel better. You may need topical, oral, or body-wide (systemic) treatments. Even if you have severe psoriasis, there are good ways to ...
Psoriasis is a sign that your immune system is not working properly. Proactively managing and making lifestyle changes to maintain a strong immune system may help reduce psoriasis flare-ups. While ...
Part of diagnosing rheumatoid arthritis (RA) involves ruling out other conditions that mimic RA, such as fibromyalgia, Lyme disease, and osteoarthritis. Diagnosis involves a physical examination, a ...
Scalp psoriasis is a common skin disorder. It may look different on different skin tones. If you're light- to medium-skinned, it often shows up as raised, reddish, or salmon-colored patches with ...
The combination of patient-reported outcomes evaluating pain, quality of life, and general health demonstrated discriminative ability for detecting active disease among patients with rheumatoid ...
Sunshine Lake Pharma Co Ltd. has divulged non-receptor tyrosine-protein kinase TYK2 inhibitors reported to be useful for the treatment of multiple sclerosis, psoriasis, rheumatoid arthritis, atopic ...